VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Are global nephrology guidelines feasible?
Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer.
Exosome-mediated delivery of CRISPR/Cas9 for targeting of oncogenic KrasG12D in pancreatic cancer. Life Sci Alliance. 2021 09; 4(9).
View in:
PubMed
subject areas
Alleles
Allografts
Animals
Biological Transport
Cell Line, Tumor
Cell Proliferation
CRISPR-Cas Systems
Disease Models, Animal
Exosomes
Gene Editing
Gene Expression Regulation, Neoplastic
Gene Targeting
Gene Transfer Techniques
Genes, Reporter
MAP Kinase Signaling System
Mice
Oncogenes
Pancreatic Neoplasms
Plasmids
Proto-Oncogene Proteins p21(ras)
authors with profiles
RAGHU KALLURI
VALERIE LEBLEU